The groundbreaking, seven-hour procedure was carried out at Hadassah Ein Kerem Medical Center by an extensive medical team ...

The FDA has granted a breakthrough device designation to the BiVACOR Total Artificial Heart. Made of titanium, the device uses a magnetically levitated rotor to pump blood in adult patients with ...

The U.S. FDA’s decision to grant breakthrough device designation for Bivacor Inc.’s titanium total artificial heart (TAH) ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...

The company has so far treated patients who were weeks or months away from a transplant, but the device is theoretically ...

Hadassah doctors performed the country’s first-ever complete artificial heart transplant on a 63-year-old patient, offering ...

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

BiVACOR, a clinical-stage medical device company developing the world's first titanium Total Artificial Heart (TAH), today announced that its device has received Breakthrough Device Designation from ...

The groundbreaking, seven-hour procedure was carried out at Hadassah Ein Kerem Medical Center by an extensive medical team, ...

Ankit Bharat, MD, can still remember Cornelia Tischmacher stopping their first telehealth conversation every few words to ...

Titanium, the main material of this artificial heart ... of the BiVACOR TAH as a temporary solution for patients suffering from severe heart failure while awaiting a transplant. Four more patients are ...

The story of transplants has always been one of altruism. After all, organs can be neither sold nor purchased. They can only ...